A Study to Investigate 14C-bemcentinib in Healthy Male Subjects

Clinical trial NCT06469138 · COMPLETED

Trial details

NCT number: NCT06469138
Sponsor: BerGenBio ASA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Metastatic Melanoma Acute Myeloid Leukemia Myelodysplastic Syndromes Metastatic Pancreatic Cancer Glioblastoma Malignant Mesothelioma COVID-19

Start date: 2022-08-02
Primary completion: 2022-09-23
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.